Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Pharma Technology Focus – Issue 75
  2. Brexit and the pharmaceutical industry: guidelines for drug precursors in case of a no-deal
  3. US Appeals Court upholds ruling on CRISPR patents in favour of Broad Institute
  4. NICE rejects NHS use of Roche’s Ocrevus for PPMS
  5. Cannabinoids breakthrough signals hope for epilepsy treatment

Latest Content

NICE rejects NHS use of Roche’s Ocrevus for PPMS

In its final draft guidance, the UK’s pricing regulator the National Institute of Health and Care Excellence (NICE) has not recommended Roche’s Ocrevus (ocrelizumab) for routine National Health Service (NHS) use to treat primary progressive multiple sclerosis (PPMS).

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top